India's Marksans Pharma rises with Australian market entry
** India's Marksans Pharma MARK.NS rises 5% ** Co says Goa facility gets Australian nod for exports ** Stock set for third consecutive session of gains ** More than 1.7 mln shares change hands, 1.2x of 30-day avg ** Stock cuts YTD loss to ~27% (Reporting by Ashish Chandra in Bengaluru) ((ashish.chandra@thomsonreuters.com (+91 7982114624))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg